Aug 07, 2019 / 08:30PM GMT
Operator
Good day, ladies and gentlemen, and welcome to the Dynavax Technologies Second Quarter 2019 Conference Call. As a reminder, this conference call is being recorded.
I would now like to introduce your host for today's conference, Ms. Heather Rowe, Vice President of Investor Relations and Corporate Communications. You may go ahead.
Heather Rowe - Dynavax Technologies Corporation - VP of IR & Corporate Communications
Thank you, operator. Good afternoon, and welcome to the Dynavax Second Quarter 2019 Financial Results and Corporate Update Conference Call. With me today are Ryan Spencer, Co-President and Senior Vice President, Commercial; and Michael Ostrach, Chief Financial Officer.
Before we begin, I advise you that we will be making forward-looking statements today, including statements about HEPLISAV-B's commercial profile and expectations regarding HEPLISAV-B, including the amount and timing of revenue, rates of adoption and reorder, clinical and financial information and our abilities to successfully pursue strategic alternatives for our
Q2 2019 Dynavax Technologies Corp Earnings Call Transcript
Aug 08, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers